LUNCH SYMPOSIUM THURSDAY 2 NOVEMBER 2017, 12:15 - 13:15
Using One Health approach to combat AMR
Organised by LIF, the trade association for the research-based pharmaceutical industry in Sweden, representing about 85 members and associate companies
AMR is a major public health issue - in 2001, the World Health Organization (WHO) described antimicrobial resistance (AMR) as ‘a global problem requiring a global response’. No single actor can address this complex issue alone. Action is required across all sectors and stakeholders, including governments, the pharmaceutical and medical diagnostics industries, academia, civil society, healthcare providers and patients, in order to find solutions.
The One Health concept typically considers three environments: human, animal, and physical. AMR – being a global problem of complex epidemiology – is well suited to a broad, integrated One Health approach. Resistant organisms exist in humans, animals, and in the environment. Implementation of the One Health approach requires purposeful consideration of interdependent compartments, their related interfaces, and the final health outcomes. The combat of AMR clearly benefits from a One Health approach as a risk-based perspective, including risk analysis, containment, avoidance and mitigation.
Examples that will be presented at this lunch symposium - and their complex interrelationships discussed - include:
- Responsible use of antibiotics in both humans and animals
- R & D into new antimicrobials
- Use of existing antimicrobials
- New business models: the concept of ‘de-linking’
- Vaccines and immunization programs
- Hygiene and sanitation
- immune-system enhancing activities
- Communication and information dissemination